院外心脏骤停后高碳酸血症患者PaCO2变化速率与功能预后的关联:一项随机临床试验的二次分析
本研究为ROC ALPS试验的二次分析,纳入ROSC后首次PaCO2>45 mmHg且至少记录2次PaCO2的746例院外心脏骤停患者。PaCO2变化速率按第二次与第一次PaCO2差值除以时间间隔计算,中位4.7 mmHg/小时(IQR 1.7–12)。主要终点出院时mRS 0–3为良好功能预后,共264例(35.4%)达到。多变量logistic回归校正混杂后,PaCO2变化速率与功能预后无独立关联(OR 0.994,95%CI 0.985–1.004,p=0.230),但与院内死亡率独立相关(OR 1.010,95%CI 1.001–1.019,p=0.029)。作者认为PaCO2下降速率越快可能与院内死亡率升高相关。
要点
- 在ROSC后首次PaCO2>45 mmHg且至少2次PaCO2记录的OHCA患者中,PaCO2变化速率与出院时良好功能预后(mRS 0–3)无独立关联(OR 0.994,95%CI 0.985–1.004,p=0.230)。
- PaCO2变化速率与院内死亡率独立相关(OR 1.010,95%CI 1.001–1.019,p=0.029),作者指出存在PaCO2下降速率越快院内死亡率越高的显著趋势。
- 746例高碳酸血症患者中264例(35.4%)出院时功能预后良好,PaCO2变化速率中位数为4.7 mmHg/小时(IQR 1.7–12)。
- 该研究为ROC ALPS试验的二次分析,PaCO2变化速率按第二次与第一次PaCO2差值除以时间间隔计算,仅纳入至少2次PaCO2记录者。
适用人群与场景
- 院外心脏骤停(OHCA)患者,ROSC后首次PaCO2>45 mmHg(高碳酸血症),且至少记录2次PaCO2。
诊断标准与关键阈值
- 高碳酸血症定义为ROSC后首次PaCO2>45 mmHg。
- 功能预后采用出院时改良Rankin量表(mRS)二分:良好为mRS 0–3,不良为mRS 4–6。
- PaCO2变化速率=第二次与第一次PaCO2差值/时间间隔,中位4.7 mmHg/小时(IQR 1.7–12)。
研究设计与关键结果
- 研究类型:ROC ALPS试验(胺碘酮、利多卡因、安慰剂试验)的二次分析。
- 样本量:746例高碳酸血症患者,其中264例(35.4%)出院时功能预后良好。
- 主要终点:校正混杂因素后,PaCO2变化速率与出院时功能预后无独立关联(OR 0.994,95%CI 0.985–1.004,p=0.230)。
- 关键次要终点:PaCO2变化速率与院内死亡率独立相关(OR 1.010,95%CI 1.001–1.019,p=0.029),作者报告PaCO2下降速率越快院内死亡率越高的显著趋势。
证据类型、等级与局限
- 证据类型:随机对照试验的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对于入院时高碳酸血症的OHCA患者,PaCO2变化速率与功能预后无独立关联,但PaCO2下降速率越快可能与院内死亡率升高相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Normocapnia is suggested for post resuscitation care. For patients with hypercapnia after cardiac arrest, the relationship between rate of change in partial pressure of carbon dioxide (PaCO2) and functional outcome was unknown.
METHODS: This was the secondary analysis of Resuscitation Outcomes Consortium (ROC) amiodarone, lidocaine, and placebo (ALPS) trial. Patients with at least 2 PaCO2 recorded and the first indicating hypercapnia (PaCO2 > 45 mmHg) after return of spontaneous circulation (ROSC) were included. The rate of change in PaCO2 was calculated as the ratio of the difference between the second and first PaCO2 to the time interval. The primary outcome was modified Rankin Score (mRS), dichotomized to good (mRS 0-3) and poor (mRS 4-6) outcomes at hospital discharge. The independent relationship between rate of change in PaCO2 and outcome was investigated with multivariable logistic regression model.
RESULTS: A total of 746 patients with hypercapnia were included for analysis, of which 264 (35.4%) patients had good functional outcome. The median rate of change in PaCO2 was 4.7 (interquartile range [IQR] 1.7-12) mmHg per hour. After adjusting for confounders, the rate of change in PaCO2 (odds ratio [OR] 0.994, confidence interval [CI] 0.985-1.004, p = 0.230) was not associated the functional outcome. However, rate of change in PaCO2 (OR 1.010, CI 1.001-1.019, p = 0.029) was independently associated with hospital mortality.
CONCLUSIONS: For OHCA patients with hypercapnia on admission, the rate of change in PaCO2 was not independently associated with functional outcome; however, there was a significant trend that higher decreased rate was associated with increased hospital mortality.
参考来源
- Zhou D, Lv Y, Lin Q, et al. Association between rate of change in PaCO2 and functional outcome for patients with hypercapnia after out-of-hospital cardiac arrest: Secondary analysis of a randomized clinical trial. Am J Emerg Med. 2023. PMID: 36634567. doi:10.1016/j.ajem.2023.01.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。